3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Neoplasms
4
Prostatic Neoplasms
2
Multiple Myeloma
2
Melanoma
2
Kidney Neoplasms
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Substance-Related Disorders
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Interventions
Brachytherapy
4
fludarabine phosphate
3
Radiotherapy
3
Radiosurgery
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
fludarabine
2
aldesleukin
2
aflibercept
2
Vaccines, Synthetic
2
Trastuzumab
2
Topotecan
2
Therapeutics
2
Surveys and Questionnaires
2
Psychiatric Rehabilitation
2
Paclitaxel
2
Methods
2
Magnetic Resonance Spectroscopy
2
Early Intervention, Educational
2
Cyclophosphamide
2
Counseling
2
Cisplatin
2
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
2
tremelimumab
1
tipifarnib
1
temsirolimus
1
entinostat
1
durvalumab
1
alovudine
1
Vinorelbine
1
Vaccines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Vaginal Neoplasms
×
Patient Reported Outcome Measures
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled